Literature DB >> 6602199

Cyclical antiidiotypic response to anti-hormone antibodies due to neutralization by autologous anti-antiidiotype antibodies that bind hormone.

P O Couraud, B Z Lü, A D Strosberg.   

Abstract

Antiidiotype antibodies were raised against anti-catecholamine ligand antibodies. The antiidiotype response was shown to be cyclical and to correspond to the production of antibodies that could bind to catecholamine beta-adrenergic receptors and stimulate adenylate cyclase. Disappearance of these antibodies from the serum could be correlated with the appearance of a catecholamine ligand-binding activity corresponding to the synthesis of autologous anti-antiidiotype antibodies directed against the induced antiidiotypic molecules. Comparison of the injected versus the induced anti-ligand antibodies reveals striking differences in affinities but similarities in the ability to bind to the antiidiotype antibodies and to the ligand-containing affinity gel. The results support the existence of a functional network of idiotype antiidiotype interactions involving external as well as internal antigens, antibodies, and possibly other types of molecules involved in recognition phenomena, such as hormone receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602199      PMCID: PMC2187015          DOI: 10.1084/jem.157.5.1369

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  ANTI-ANTIBODY OR CLONE-PRODUCT?

Authors:  P G GELL; A S KELUS
Journal:  Nature       Date:  1964-02-15       Impact factor: 49.962

2.  [A new allotype form of rabbit serum gamma-globulins, apparently associated with antibody function and specificity].

Authors:  J OUDIN; M MICHEL
Journal:  C R Hebd Seances Acad Sci       Date:  1963-07-17

3.  Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol.

Authors:  G Vauquelin; S Bottari; L Kanarek; A D Strosberg
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

4.  Individual Antigenic Specificity of Isolated Antibodies.

Authors:  H G Kunkel; M Mannik; R C Williams
Journal:  Science       Date:  1963-06-14       Impact factor: 47.728

5.  The production and characterization of antibodies against beta-adrenergic antagonists.

Authors:  J Hoebeke; G Vauquelin; A D Strosberg
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

7.  Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase.

Authors:  A B Schreiber; P O Couraud; C Andre; B Vray; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Anti-idiotypic antibodies against anti-vitamin A transporting protein react with prealbumin.

Authors:  K Sege; P A Peterson
Journal:  Nature       Date:  1978-01-12       Impact factor: 49.962

9.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

10.  An antiidiotypic antibody that recognizes the beta-adrenergic receptor.

Authors:  C J Homcy; S G Rockson; E Haber
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

View more
  3 in total

Review 1.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

2.  beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody.

Authors:  J G Guillet; S V Kaveri; O Durieu; C Delavier; J Hoebeke; A D Strosberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

Review 3.  Anti-idiotype and anti-hormone receptor antibodies.

Authors:  A D Strosberg
Journal:  Springer Semin Immunopathol       Date:  1983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.